检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:马奔[1] 吕军[1] 曾北蓝[1] 张浩[1] 陈春林[2] 刘萍[2]
机构地区:[1]广州医学院附属广州市第一人民医院妇产科,广东广州510182 [2]南方医科大学附属南方医院妇产科
出 处:《中国妇幼保健》2011年第8期1260-1262,共3页Maternal and Child Health Care of China
摘 要:目的:探讨子宫动脉灌注化疗加栓塞在宫颈妊娠治疗中的临床应用。方法:对15例停经45~92天的宫颈妊娠患者行子宫动脉MTX或卡铂灌注化疗加栓塞术,术后观察不同时间的病灶大小、血HCG值变化及结局。结果:14例行一次子宫动脉灌注化疗加栓塞,1例行2次子宫动脉灌注化疗加栓塞,术后血HCG值均明显下降,病灶大小与血HCG值变化无关。14例安全行清宫术,1例因清宫术再出血行第2次灌注加栓塞。结论:子宫动脉灌注加栓塞能够迅速、有效杀灭胚胎,制止宫颈妊娠出血,使血HCG值快速下降,降低清宫时的风险,是治疗宫颈妊娠安全、有效的方法。同时,在化疗药物的选择、清宫时机的把握等方面尚需进一步研究。Objective: To study the clinical application of uterine artery chemoembolization in treating cervical pregnancy. Methods: Uterine artery chemoembolization was done on 15 cases of cervical pregnancy which were amenorrhea for 45 to 92 days,then the changing of ectopic mass size,Serumβ-HCG and the treating result were observed. Results: 14 patients were done by uterine artery chemoembolization once.1 case was done by uterine artery chemoembolization twice.Serum β-HCG was found obviously lower in all cases,and the change of the ectopic mass size had no relation with the change of Serum β-HCG.Cleaning of the uterus and the cervix uteri was carried out safely after uterine artery chemoembolization.Bleeding was occurred in 1 patient after cleaning of the uterus and the cervix uteri,and the second time of uterine artery chemoembolization was done. Conclusion:Uterine artery chemoembolization is an effective and save treatment for cervical pregnancy,it can kill the ectopic pregnancy mass and lower the serum β-HCG quickly.Also it can lower the risk of cleaning of the uterus and the cervix uteri.Otherwise,it still needs further research for the selection of drug type used in uterine artery chemoembolization and the right time for cleaning of the uterus and the cervix uteri after uterine artery chemoembolization.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117